Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Online adaptive MR-guided radiotherapy: Conformity of contour adaptation for prostate cancer, rectal cancer and lymph node oligometastases among radiation therapists and radiation oncologists.
Rasing MJA, Sikkes GG, Vissers NGPM, Kotte ANTJ, Boudewijn JH, Doornaert PAH, Eppinga WSC, Intven M, Rutgers RHA, Scheeren A, Snoeren LMW, Vlig TB, van der Voort van Zyp JRN, Wijkhuizen LM, van Rossum PSN, Peters M, Jürgenliemk-Schulz IM. Rasing MJA, et al. Tech Innov Patient Support Radiat Oncol. 2022 Aug 24;23:33-40. doi: 10.1016/j.tipsro.2022.08.004. eCollection 2022 Sep. Tech Innov Patient Support Radiat Oncol. 2022. PMID: 36090011 Free PMC article.
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.
Vermij L, Jobsen JJ, León-Castillo A, Brinkhuis M, Roothaan S, Powell ME, de Boer SM, Khaw P, Mileshkin LR, Fyles A, Leary A, Genestie C, Jürgenliemk-Schulz IM, Crosbie EJ, Mackay HJ, Nijman HW, Nout RA, Smit VTHBM, Creutzberg CL, Horeweg N, Bosse T; TransPORTEC Consortium. Vermij L, et al. Br J Cancer. 2023 Mar;128(7):1360-1368. doi: 10.1038/s41416-023-02141-0. Epub 2023 Jan 23. Br J Cancer. 2023. PMID: 36690721 Free PMC article.
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.
Kaya M, Post CCB, Tops CM, Nielsen M, Crosbie EJ, Leary A, Mileshkin LR, Han K, Bessette P, de Boer SM, Jürgenliemk-Schulz IM, Lutgens L, Jobsen JJ, Haverkort MAD, Nout RA, Kroep J, Creutzberg CL, Smit VTHBM, Horeweg N, van Wezel T, Bosse T. Kaya M, et al. Among authors: jurgenliemk schulz im. Mod Pathol. 2024 Mar;37(3):100423. doi: 10.1016/j.modpat.2024.100423. Epub 2024 Jan 6. Mod Pathol. 2024. PMID: 38191122 Free article.
Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.
Fremond S, Andani S, Barkey Wolf J, Dijkstra J, Melsbach S, Jobsen JJ, Brinkhuis M, Roothaan S, Jurgenliemk-Schulz I, Lutgens LCHW, Nout RA, van der Steen-Banasik EM, de Boer SM, Powell ME, Singh N, Mileshkin LR, Mackay HJ, Leary A, Nijman HW, Smit VTHBM, Creutzberg CL, Horeweg N, Koelzer VH, Bosse T. Fremond S, et al. Lancet Digit Health. 2023 Feb;5(2):e71-e82. doi: 10.1016/S2589-7500(22)00210-2. Epub 2022 Dec 7. Lancet Digit Health. 2023. PMID: 36496303 Free article. Clinical Trial.
Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases.
Werensteijn-Honingh AM, Kroon PS, Winkel D, Aalbers EM, van Asselen B, Bol GH, Brown KJ, Eppinga WSC, van Es CA, Glitzner M, de Groot-van Breugel EN, Hackett SL, Intven M, Kok JGM, Kontaxis C, Kotte AN, Lagendijk JJW, Philippens MEP, Tijssen RHN, Wolthaus JWH, Woodings SJ, Raaymakers BW, Jürgenliemk-Schulz IM. Werensteijn-Honingh AM, et al. Radiother Oncol. 2019 May;134:50-54. doi: 10.1016/j.radonc.2019.01.024. Epub 2019 Feb 1. Radiother Oncol. 2019. PMID: 31005224 Free article.
Individual lymph nodes: "See it and Zap it".
Winkel D, Werensteijn-Honingh AM, Kroon PS, Eppinga WSC, Bol GH, Intven MPW, de Boer HCJ, Snoeren LMW, Hes J, Raaymakers BW, Jürgenliemk-Schulz IM. Winkel D, et al. Clin Transl Radiat Oncol. 2019 Mar 30;18:46-53. doi: 10.1016/j.ctro.2019.03.004. eCollection 2019 Sep. Clin Transl Radiat Oncol. 2019. PMID: 31341975 Free PMC article.
Adaptive radiotherapy: The Elekta Unity MR-linac concept.
Winkel D, Bol GH, Kroon PS, van Asselen B, Hackett SS, Werensteijn-Honingh AM, Intven MPW, Eppinga WSC, Tijssen RHN, Kerkmeijer LGW, de Boer HCJ, Mook S, Meijer GJ, Hes J, Willemsen-Bosman M, de Groot-van Breugel EN, Jürgenliemk-Schulz IM, Raaymakers BW. Winkel D, et al. Clin Transl Radiat Oncol. 2019 Apr 2;18:54-59. doi: 10.1016/j.ctro.2019.04.001. eCollection 2019 Sep. Clin Transl Radiat Oncol. 2019. PMID: 31341976 Free PMC article.
Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment.
Winkel D, Bol GH, Werensteijn-Honingh AM, Intven MPW, Eppinga WSC, Hes J, Snoeren LMW, Sikkes GG, Gadellaa-van Hooijdonk CGM, Raaymakers BW, Jürgenliemk-Schulz IM, Kroon PS. Winkel D, et al. Radiother Oncol. 2020 May;146:118-125. doi: 10.1016/j.radonc.2020.02.011. Epub 2020 Mar 6. Radiother Oncol. 2020. PMID: 32146257 Free article.
136 results